Implantable Defibrillators Risk Therapy Failure Due to Feedthrough Defect
Certain Medtronic implantable cardioverter defibrillators may fail to deliver high-voltage therapy due to a specific feedthrough defect. The 4,767 affected units were distributed nationwide and worldwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I designation requires a minimum score of 4. This defect poses a serious patient safety risk by potentially preventing lifesaving high-voltage therapy delivery in critical cardiac situations, though no illnesses or deaths have been reported.
Plain-English summary
Medtronic Inc. is recalling certain CRTD DTMB2Q1 AMPLIA MRI QUAD OUS DF1 implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific glassed feedthrough. This defect creates a rare potential for reduced or no-energy output during high-voltage (HV) therapy, typically when delivering 0 to 12 joules of energy.
The affected devices may fail to deliver adequate therapy to patients who depend on these implanted devices to treat life-threatening heart rhythms. A total of 4,767 units with specific lot serial numbers were distributed throughout the United States and worldwide.
Patients who have received one of the affected devices should contact Medtronic or their implanting cardiologist or electrophysiologist for guidance. Healthcare providers can identify potentially affected units using the provided lot serial numbers and determine whether device replacement or other clinical intervention is necessary.
The recalled product
- Product
- CRTD DTMB2Q1 AMPLIA MRI QUAD OUS DF1, Model Number DTMB2Q1; Implantable Cardioverter Defibrillators
- Affected units
- 4,767
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- GTIN 00643169837638
- Lot Serial Numbers: RPP602125S
- RPP602593S
- RPP603699S
- RPP602902S
- RPP602417S
- RPP601873S
- RPP602956S
- RPP601533S
- RPP603620S
- RPP600808S
- RPP603725S
- RPP602431S
- RPP602451S
- RPP602452S
- RPP602460S
- RPP602737S
- RPP602741S
- RPP602778S
- RPP602780S
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 120 recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 120 products in this recall →Related recalls
Same manufacturer · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
See all →- SevereMedtronic CRT-D and ICD Defibrillators Recalled for Potential Therapy Output Failure
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators at Risk of Reduced Energy Output
FDA (Devices) · 2023-06-28
- CriticalMedtronic CRT-D Defibrillators: Rare Energy Output Failure Risk During Therapy
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Defibrillators Recalled for Potential Therapy Delivery Failure
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillator may lose energy output during therapy
FDA (Devices) · 2023-06-28
Same hazard · device malfunction
See all →- HighPhilips Incisive CT Recalled for Potential Failure to Trigger Clinical Scan
FDA (Devices) · 2026-09-02
- HighBoston Scientific Recalls Suture Cinch Endoscopic Tissue Approximation Devices
FDA (Devices) · 2026-08-26
- HighBD Needle Kit for Powered Driver Recall Due to Removal Difficulty
FDA (Devices) · 2026-08-26
- SevereStryker AHTO Tube Set Packaging Recalled for Handpiece Leaking
FDA (Devices) · 2026-08-12
- SevereGEM Premier 5000 PAK Lysing Solution Concentration Recall
FDA (Devices) · 2026-08-12